Hikma Pharmaceuticals
London · Founded 1978
About Hikma Pharmaceuticals
Hikma was founded in 1978 in Amman, Jordan by Samih Darwazah, our current Chairman and CEO. In the early years, the Company’s primary focus was on developing a branded pharmaceuticals business across the MENA Region. Then in the early 1990’s, Hikma expanded outside the MENA Region by acquiring a generic pharmaceuticals business in the United States and by establishing injectable pharmaceutical operations in Portugal. Since then, the company has expanded significantly, both organically and through acquisition.
Company Facts
- Founded: 1978
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 5,001 – 10,000
- Estimated revenue: $1M – $10M
- Total funding: $250.0M
- Funding stage: IPO
- Last round: Post-IPO Debt (Jul 2025)
- Ticker: lse:HIK
- Website: hikma.com
- Phone: +962 6 580 2900
Industries & Categories
Health Care, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/hikma-pharmaceuticals-58530 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.